CRNX
Price
$47.27
Change
-$2.70 (-5.40%)
Updated
Feb 4, 02:36 PM (EDT)
Capitalization
5.12B
22 days until earnings call
Intraday BUY SELL Signals
TRDA
Price
$10.90
Change
-$0.89 (-7.55%)
Updated
Feb 4, 03:21 PM (EDT)
Capitalization
449.84M
42 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CRNX vs TRDA

Header iconCRNX vs TRDA Comparison
Open Charts CRNX vs TRDABanner chart's image
Crinetics Pharmaceuticals
Price$47.27
Change-$2.70 (-5.40%)
Volume$1.82K
Capitalization5.12B
Entrada Therapeutics
Price$10.90
Change-$0.89 (-7.55%)
Volume$467
Capitalization449.84M
CRNX vs TRDA Comparison Chart in %
CRNX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CRNX vs. TRDA commentary
Feb 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRNX is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 04, 2026
Stock price -- (CRNX: $49.96 vs. TRDA: $11.79)
Brand notoriety: CRNX and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRNX: 66% vs. TRDA: 79%
Market capitalization -- CRNX: $5.12B vs. TRDA: $449.84M
CRNX [@Biotechnology] is valued at $5.12B. TRDA’s [@Biotechnology] market capitalization is $449.84M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRNX’s FA Score shows that 0 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • CRNX’s FA Score: 0 green, 5 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, CRNX is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRNX’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 3 bullish TA indicator(s).

  • CRNX’s TA Score: 3 bullish, 4 bearish.
  • TRDA’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both CRNX and TRDA are a bad buy in the short-term.

Price Growth

CRNX (@Biotechnology) experienced а -5.67% price change this week, while TRDA (@Biotechnology) price change was +7.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.39%. For the same industry, the average monthly price growth was +1.48%, and the average quarterly price growth was +33.05%.

Reported Earning Dates

CRNX is expected to report earnings on Feb 26, 2026.

TRDA is expected to report earnings on Mar 18, 2026.

Industries' Descriptions

@Biotechnology (-2.39% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRNX($5.12B) has a higher market cap than TRDA($450M). TRDA YTD gains are higher at: 14.689 vs. CRNX (7.325). TRDA has higher annual earnings (EBITDA): -117.36M vs. CRNX (-474.16M). CRNX has more cash in the bank: 1.09B vs. TRDA (327M). CRNX has less debt than TRDA: CRNX (49.1M) vs TRDA (52.4M). TRDA has higher revenues than CRNX: TRDA (61.5M) vs CRNX (1.54M).
CRNXTRDACRNX / TRDA
Capitalization5.12B450M1,138%
EBITDA-474.16M-117.36M404%
Gain YTD7.32514.68950%
P/E RatioN/A10.26-
Revenue1.54M61.5M2%
Total Cash1.09B327M334%
Total Debt49.1M52.4M94%
FUNDAMENTALS RATINGS
CRNX: Fundamental Ratings
CRNX
OUTLOOK RATING
1..100
67
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
48
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRNXTRDA
RSI
ODDS (%)
Bearish Trend 2 days ago
79%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 21 days ago
75%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CRNX
Daily Signal:
Gain/Loss:
TRDA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FDESX39.76N/A
N/A
Fidelity Advisor Diversified Stock O
GGHSX40.63-0.24
-0.59%
Invesco Health Care R6
CPEIX23.50-0.24
-1.01%
Catalyst Dynamic Alpha I
RAFEX44.78-0.88
-1.93%
American Funds AMCAP R4
ELCRX37.46-0.75
-1.96%
Eaton Vance Growth R

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with NRIX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.51%
NRIX - TRDA
51%
Loosely correlated
-1.76%
CRNX - TRDA
50%
Loosely correlated
+1.24%
IDYA - TRDA
50%
Loosely correlated
+0.50%
KYMR - TRDA
48%
Loosely correlated
+2.12%
RARE - TRDA
48%
Loosely correlated
+0.16%
More